Symposium 2: New renal protection strategies in mellitus diabetes type 2

Authors

  • Alicia Elbert Center for Renal Disease and Arterial Hypertension (CEREHA), Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/diab.v56i3Sup.492

Keywords:

diabetes mellitus, kidney disease

Abstract

In recent years, the NKF National Kidney Foundation modified the term "diabetic nephropathy" which is only used for biopsy-confirmed pathology using the termof diabetic kidney disease (CKD) in order to understand that some patients with diabetes can have renal disease of another etiology, so it should be promptly referred to the nephrologist to diagnose and carry out the appropriate treatment.

However, as we will develop in this exchange, currently the paradigm in the choice of medication for diabetes has been modified from the glucocentric to a metabolic cardiorenal perspective that has allowed us to combine some concepts to establish better choices in treatment and avoid the appearance and/or CKD progression.

The patients we approach not only have diabetes but also have obesity beyond the high prevalence of hypertension, dyslipidemia and other glomerulopathies, etc. that can be submitted together.

Author Biography

Alicia Elbert, Center for Renal Disease and Arterial Hypertension (CEREHA), Autonomous City of Buenos Aires, Argentina

Nephrologist specializing in Diabetes; Director of the Center for Renal Disease and Arterial Hypertension (CEREHA)

References

I. Dasgupta I, Zoccali C. Is the KDIGO systolic blood pressure target <120 mmHg for chronic kidney disease appropriate in routine clinical practice? Hypertension 2022 Jan;79(1):4-11.

II. Mottl AK, Alicic R, Argyropoulos C, Brosius FC, Mauer M, Molitch M, Nelson RG, Perreault L, Nicholas SB. KDOQI US Commentary on the KDIGO 2020 clinical practice guideline for diabetes management in CKD. Am J Kidney Dis 2022 Apr;79(4):457-479.

Downloads

Published

2022-09-01

How to Cite

Elbert, A. (2022). Symposium 2: New renal protection strategies in mellitus diabetes type 2. Journal of the Argentine Society of Diabetes, 56(3Sup), 7–7. https://doi.org/10.47196/diab.v56i3Sup.492

Issue

Vol. 56 No. 3Sup (2022): September/December 2022

Section

Symposium Part 1

License

Copyright (c) 2022 on behalf of the authors. Reproduction rights: Argentine Diabetes Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.

La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.

Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.

 

Similar Articles

1 2 3 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

<< < 1 2